Neutrolin® and biofilm formation

Heparin 7 months
Neutrolin® 5 months

Figure 1 shows two scanning electron microscope (SEM) photos of the luminal surfaces from two different catheters. The left catheter was removed from the HD patient who had been using a conventional heparin lock for 7 months. The photo on the right of an HD patient using Neutrolin* locked catheter has no evidence of any biofilm after 5 months in vivo.4

Validated Clinical Utility in “EU Real World” Setting – Neutrolin® Usage Monitoring Program (NUMP)

  • From January 2014 to November 2015, 19 hemodialysis centers in Germany participated in  Neutrolin® Usage Monitoring Program
  • 199 HD patients representing 15,122 dialysis sessions over a 22 months period for a total of  35,285 hemodialysis catheter days
  • 5 infections and 3 thrombosis events over the 35,285 hemodialysis catheter days
  • The primary outcome of our study is to monitor safety and efficacy of Neutrolin® in preventing  infection and thrombosis in HD patients
Complication (per 1,000 catheter days) Historical Benchmark Neutrolin® % Reduction in Infection Rate
Infection
Thrombosis		 3.5
2–3		 0.142
0.085		 96.0 %
96.6 %

Positive results are consistent with prior clinical studies

Sales representant request

Download instructions of use

Download information for dialysis efficiency

1) CDC Guidelines for the Prevention of Intravascular Catheter Related Infections; 2) O`Grady et al., 2011; Morris P, Knechtle SJ. Kidney Transplantation - Principles and Practice. Saunders, 2013. 3) Napalkov P, Felici DM, Chu LK, Jacobs JR, Begelman SM. Incidence of catheter-related complications in patients with central venous or hemodialysis catheters: a health care claims database analysis. BMC Cardiovasc Disord. 2013 Oct 16;13:86. doi: 10.1186/1471-2261-13-86. PubMed PMID: 24131509; PubMed Central PMCID: PMC4015481 4) Quarello F, Forneris G. Prevention of hemodialysis catheter-related bloodstream infection using an antimicrobial lock. Blood Purif. 2002;20(1): 87-92. Review. PubMed PMID: 11803164. 5) Napalkov P, Felici DM, Chu LK, Jacobs JR, Begelman SM. Incidence of catheter-related complications in patients with central venous or hemodialysis catheters: a health care claims database analysis. BMC Cardiovasc Disord. 2013 Oct 16;13:86. doi: 10.1186/1471-2261-13-86. PubMed PMID: 24131509; PubMed Central PMCID: PMC4015481